hims wegovy - Search News

News

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers

The Motley Fool on MSN · 13h

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ending of its deal with Hims & Hers jeopardizes the healthcare platform's goal to lead the weight loss market.

CBS News on MSN · 1d

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

Reuters on MSN · 1d

Novo, Hims & Hers engage in war of words after Wegovy deal falls apart

Novo Nordisk ended a short-lived agreement to sell its Wegovy weight-loss drug through Hims & Hers Health on Monday, sending shares of the U.S. telehealth company plunging more than 30%. The companies,

23hon MSN

Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.

Hims & Hers Health’s stock booked record losses Monday after Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ...

3h

Long Island experts weigh in after Novo Nordisk ends deal with Hims & Hers over weight loss meds

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...

5h

HIMS Crashes On Novo GLP-1 Fallout: Buy-The-Dip Or Bail?

Telehealth company Hims & Hers (HIMS) saw a 34% stock drop after Novo Nordisk (NVO) ended their relationship. Investors must ...

StockStory.org on MSN1d

Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 29.2% in the morning session after Novo Nordisk, the maker ...

Zacks Investment Research on MSN5d

Hims & Hers Stock Jumps 85.1% in 3 Months: Is It a Buy Now?

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock lately despite its ...

8hon MSN

Novo Nordisk launches weight-loss drug Wegovy in India to compete with Lilly's Mounjaro

Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results